Should the new EASL-EASD-EASO Clinical Practice Guidelines on MASLD recommend pioglitazone as a MASH-targeted pharmacotherapy?

Silva Júnior, Wellington S; Sposito, Andrei C; Godoy-Matos, Amélio

Silva Júnior, Wellington S; Sposito, Andrei C; Godoy-Matos, Amélio.

Affiliation

Silva Júnior WS; Universidade Federal do Maranhão (UFMA), Sao Luis (MA), Brazil. Electronic address: wellington.santana@ufma.br.
Sposito AC; Universidade Estadual de Campinas (Unicamp), Campinas (SP), Brazil. Electronic address: sposito@unicamp.br.
Godoy-Matos A; Instituto Estadual de Diabetes e Endocrinologia do Rio de Janeiro (IEDE), Rio de Janeiro (RJ), Brazil. Electronic address: agodoymatos@gmail.com.

J Hepatol ; 2024 Jul 04.

Article in En | MEDLINE | ID: mdl-38971532

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2024 Type: Article